| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,824 |
13,394 |
$534K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,309 |
4,288 |
$269K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,702 |
1,672 |
$95K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,612 |
1,592 |
$78K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
778 |
776 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,499 |
2,464 |
$29K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
335 |
333 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,188 |
1,175 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
520 |
334 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
42 |
41 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
122 |
121 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
137 |
132 |
$2K |
| 81003 |
|
828 |
813 |
$1K |
| 87634 |
|
14 |
14 |
$866.88 |
| 87807 |
|
72 |
72 |
$798.94 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
25 |
25 |
$224.36 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
67 |
63 |
$8.31 |